WILMINGTON, Del. & LYON, France–(BUSINESS WIRE)– Ananda Scientific Inc., a clinical-stage drug development company advancing innovative therapies for high-impact neuropsychiatric disorders, today announced the signing of a Memorandum of Understanding (MOU) with Benta SAS. The MOU expresses the parties’ intent to explore a potential collaboration focused on accelerating the development and future availability of… Continue reading Ananda Scientific and Benta Sign Memorandum on Advancing Treatments for PTSD